iv-drip-summary

First immunotherapy approved for type 1 diabetes

... but teplizumab yet to receive the thumbs-up from NICE.

19 Aug 2025

tuberculosis-summary

Limit TB drugs to one month’s supply, warns MHRA amid shortages

Prioritise active TB cases to conserve supplies, MHRA tells prescribers

31 Jul 2025

birch-tree-pollen-summary

NICE recommends immunotherapy tablet for birch pollen allergy

Patients require positive skin prick or blood tests confirming allergy before accessing the therapy.

22 Jul 2025

eurneffy-summary2

MHRA approves first needle-free adrenaline nasal spray

EURneffy (adrenaline 2mg): ready-to-use, needle-free intranasal spray for emergency treatment of anaphylaxis.

21 Jul 2025

Change privacy settings